The potential clinical impact of low-level antibiotic resistance in Staphylococcus aureus

被引：27

作者：

Goldstein, F. ^{[1
]}

机构：

[1] St Joseph Hosp, F-75014 Paris, France

来源：

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 2007年 / 59卷 / 01期

关键词：

borderline activity; staphylococci; antimicrobials;

D O I：

10.1093/jac/dkl429

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

Low-level antibiotic resistance in Staphylococcus aureus is a frequently overlooked phenomenon, usually not detected by standard susceptibility testing procedures. It represents a gateway to high-level clinically relevant resistance. Moreover, low-level resistance may be associated with increased virulence, resistance to unrelated compounds and more successful in vivo survival.

引用

收藏

页码：1 / 4

页数：4

相关论文

共 37 条

[1]

ACAR JF, 1978, J CLIN MICROBIOL, V8, P142

[2] Different aminoglycoside-resistant phenotypes in a rabbit Staphylococcus aureus endocarditis infection model [J].

Asseray, N ;

Caillon, J ;

Roux, N ;

Jacqueline, C ;

Bismuth, R ;

Kergueris, MF ;

Potel, G ;

Bugnon, D .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (05) :1591-1593

[3] Low-level antibacterial resistance: a gateway to clinical resistance [J].

Baquero, F .

DRUG RESISTANCE UPDATES, 2001, 4 (02) :93-105

[4] Compensatory adaptation to the loss of biological fitness associated with acquisition of fusidic acid resistance in Staphylococcus aureus [J].

Besier, S ;

Ludwig, A ;

Brade, V ;

Wichelhaus, TA .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (04) :1426-1431

[5]

BISMUTH R, 2006, ANTIBIOGRAMME, P205

[6]

*COM ANT SOC FRANC, 1996, CLIN MICROBIOL INFEC, V2, P1

[7] Correlation between reduced daptomycin susceptibility and vancomycin resistance in vancomycin-intermediate Staphylococcus aureus [J].

Cui, LZ ;

Tominaga, E ;

Neoh, HM ;

Hiramatsu, K .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (03) :1079-1082

[8] Effect of fluoroquinolone concentration on selection of resistant mutants of Mycobacterium bovis BCG and Staphylococcus aureus [J].

Dong, YZ ;

Zhao, XL ;

Domagala, J ;

Drlica, K .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (07) :1756-1758

[9] Biofilms: Survival mechanisms of clinically relevant microorganisms [J].

Donlan, RM ;

Costerton, JW .

CLINICAL MICROBIOLOGY REVIEWS, 2002, 15 (02) :167-+

[10] The genetics of staphylococcal biofilm formation-will a greater understanding of pathogenesis lead to better management of device-related infection? [J].

Fitzpatrick, F ;

Humphreys, H ;

O'Gara, JP .

CLINICAL MICROBIOLOGY AND INFECTION, 2005, 11 (12) :967-973

← 1 2 3 4 →